AU Stock MarketDetailed Quotes
IXC Invex Therapeutics Ltd
- 0.072
- 0.0000.00%
20min DelayNot Open Jul 23 11:45 AET
5.41MMarket Cap-699P/E (Static)
0.000High0.000Low0Volume0.000Open0.072Pre Close0.00Turnover0.10552wk High0.00%Turnover Ratio75.15MShares0.03852wk Low-0.08EPS TTM3.72MFloat Cap0.522Historical HighLossP/E (Static)51.72MShs Float0.038Historical Low-0.103EPS LYR0.00%Amplitude0.19Dividend TTM1.01P/B1Lot Size258.33%Div YieldTTM
About Invex Therapeutics Ltd Company
Invex Therapeutics Ltd is a biopharmaceutical company, focused on the research and development of Exenatide as a treatment for neurological conditions such as Idiopathic Intracranial Hypertension (IIH), traumatic brain injury, or acute stroke. Its other program under development is Presendin which can be used for disabling headaches and permanent vision loss in females. Geographically, it operates only in Australia.
Company Profile
SymbolIXC
Company NameInvex Therapeutics Ltd
Founded2019
MarketASX
Fiscal Year Ends06-30
Address38 Rowland Street Level 1
CitySubiaco
CountryAustralia
Zip Code6008
Phone+61 863820137
Share RegistryAUTOMIC REGISTRY SERVICES
LEVEL 5, 191 St Georges Terrace,, PERTH, WA, AUSTRALIA, 6000
(08) 9324 2099
Company Executives
- Name
- Position
- Salary
- David McAuliffe
- Non-Executive Director
- --
- Thomas (Tom) Duthy
- Executive Director
- --
- Megan Baldwin
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg